These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 22910059)
1. The frequencies of mutated alleles of CYP2D6 gene in a Turkish population. Serin A; Canan H; Alper B; Gulmen M Forensic Sci Int; 2012 Oct; 222(1-3):332-4. PubMed ID: 22910059 [TBL] [Abstract][Full Text] [Related]
2. Frequency of mutated allele CYP2D6*4 in the Turkish population. Koseler A; Ilcol YO; Ulus IH Pharmacology; 2007; 79(4):203-6. PubMed ID: 17374963 [TBL] [Abstract][Full Text] [Related]
3. Frequency of single nucleotide polymorphisms of CYP2D6 in the Czech population. Buzková H; Pechandová K; Slanar O; Perlík F Cell Biochem Funct; 2008; 26(1):76-81. PubMed ID: 17311358 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of the CYP2D6*10 (C100T), *4 (G1846A), and *14 (G1758A) alleles among Iranians of different ethnicities. Bagheri A; Kamalidehghan B; Haghshenas M; Azadfar P; Akbari L; Sangtarash MH; Vejdandoust F; Ahmadipour F; Meng GY; Houshmand M Drug Des Devel Ther; 2015; 9():2627-34. PubMed ID: 25999696 [TBL] [Abstract][Full Text] [Related]
5. CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population. Scott SA; Edelmann L; Kornreich R; Erazo M; Desnick RJ Pharmacogenomics; 2007 Jul; 8(7):721-30. PubMed ID: 18240905 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the CYP2D6 gene mutations and their consequences for enzyme function in a West African population. Griese EU; Asante-Poku S; Ofori-Adjei D; Mikus G; Eichelbaum M Pharmacogenetics; 1999 Dec; 9(6):715-23. PubMed ID: 10634134 [TBL] [Abstract][Full Text] [Related]
7. CYP2D6 and CYP1A1 mutations in the Turkish population. Aydin M; Hatirnaz O; Erensoy N; Ozbek U Cell Biochem Funct; 2005; 23(2):133-5. PubMed ID: 15648054 [TBL] [Abstract][Full Text] [Related]
8. Polymorphisms and phenotypic analysis of cytochrome P450 2D6 in the Tibetan population. Jin TB; Ma LF; Zhang JY; Yuan DY; Sun Q; Zong TY; Geng TT; Cui YL; Kang LL; Chen C Gene; 2013 Sep; 527(1):360-5. PubMed ID: 23644254 [TBL] [Abstract][Full Text] [Related]
9. Simultaneous genotyping of CYP2D6*3, *4, *5 and *6 polymorphisms in a Spanish population through multiplex long polymerase chain reaction and minisequencing multiplex single base extension analysis. Crescenti A; Mas S; Gassó P; Baiget M; Bernardo M; Lafuente A Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):992-7. PubMed ID: 17714084 [TBL] [Abstract][Full Text] [Related]
10. High prevalence of CYP2D6*41 (G2988A) allele in Saudi Arabians. Al-Dosari MS; Al-Jenoobi FI; Alkharfy KM; Alghamdi AM; Bagulb KM; Parvez MK; Al-Mohizea AM; Al-Muhsen S; Halwani R Environ Toxicol Pharmacol; 2013 Nov; 36(3):1063-7. PubMed ID: 24121619 [TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. Sachse C; Brockmöller J; Bauer S; Roots I Am J Hum Genet; 1997 Feb; 60(2):284-95. PubMed ID: 9012401 [TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of CYP2D6 in Chinese mainland. Ji L; Pan S; Wu J; Marti-Jaun J; Hersberger M Chin Med J (Engl); 2002 Dec; 115(12):1780-4. PubMed ID: 12622923 [TBL] [Abstract][Full Text] [Related]
13. CYP2D6 genotype and phenotype in Amerindians of Tepehuano origin and Mestizos of Durango, Mexico. Sosa-Macías M; Elizondo G; Flores-Pérez C; Flores-Pérez J; Bradley-Alvarez F; Alanis-Bañuelos RE; Lares-Asseff I J Clin Pharmacol; 2006 May; 46(5):527-36. PubMed ID: 16638736 [TBL] [Abstract][Full Text] [Related]
14. Genotype and allele frequencies of MDR1 gene C1236T polymorphism in a Turkish population. Gümüş-Akay G; Rüstemoğlu A; Karadağ A; Sunguroğlu A Genet Mol Res; 2008 Oct; 7(4):1193-9. PubMed ID: 19048498 [TBL] [Abstract][Full Text] [Related]
15. The influence of CYP2D6 genotype on trough plasma perhexiline and cis-OH-perhexiline concentrations following a standard loading regimen in patients with myocardial ischaemia. Davies BJ; Coller JK; James HM; Somogyi AA; Horowitz JD; Sallustio BC Br J Clin Pharmacol; 2006 Mar; 61(3):321-5. PubMed ID: 16487226 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of a high-throughput genetic analysis in the identification of responders/non-responders to CYP2D6-metabolized drugs. Savino M; Seripa D; Gallo AP; Garrubba M; D'Onofrio G; Bizzarro A; Paroni G; Paris F; Mecocci P; Masullo C; Pilotto A; Santini SA Clin Lab; 2011; 57(11-12):887-93. PubMed ID: 22239018 [TBL] [Abstract][Full Text] [Related]
17. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients. Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169 [TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphism of CYP2D6 in the Japanese population. Chida M; Yokoi T; Kosaka Y; Chiba K; Nakamura H; Ishizaki T; Yokota J; Kinoshita M; Sato K; Inaba M; Aoki Y; Gonzalez FJ; Kamataki T Pharmacogenetics; 1999 Oct; 9(5):601-5. PubMed ID: 10591540 [TBL] [Abstract][Full Text] [Related]
19. Pilot study for the characterization of pharmacogenetically relevant CYP2D6, CYP2C19 and ABCB1 gene polymorphisms in the Hungarian population. Rideg O; Háber A; Botz L; Szücs F; Várnai R; Miseta A; Kovács GL Cell Biochem Funct; 2011 Oct; 29(7):562-8. PubMed ID: 21826689 [TBL] [Abstract][Full Text] [Related]
20. Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use. Dorado P; Cáceres MC; Pozo-Guisado E; Wong ML; Licinio J; Llerena A Biotechniques; 2005 Oct; 39(4):571-4. PubMed ID: 16235570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]